C-Met Exon 14 Mutation
1 clinical trials · Condition
◉ Watch C-Met Exon 14 Mutation
| Record | Firm | Date |
|---|---|---|
| Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer (NCT04270591) | Haihe Biopharma Co., Ltd. | 2019-07-15 |
Track C-Met Exon 14 Mutation automatically
Every clearance here is in the API, with alerts when new ones post.